Drug news
Allergan launches FDA-approved generic version of Invega (paliperidone extended-release) for treatment of schizophrenia
Allergan announced that it has launched a generic version of Invega (paliperidone extended-release tablets) from Janssen in the USA. Allergan is the first company to receive FDA approval for and launch a generic version of Invega.